Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationHematopoietic Stem CellsBone Marrow TransplantationTransplantation, HomologousBone MarrowMultiple MyelomaPeripheral Blood Stem Cell TransplantationTransplantation ConditioningBone Marrow CellsMelphalanAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34Stem CellsCombined Modality TherapyTreatment OutcomeHematopoietic Stem Cell MobilizationRemission InductionSalvage TherapyCyclophosphamideBone Marrow PurgingLymphoma, Non-HodgkinDisease-Free SurvivalHematopoiesisEtoposideHodgkin DiseaseRecurrenceCarmustineGraft vs Host DiseaseGranulocyte Colony-Stimulating FactorColony-Forming Units AssayWhole-Body IrradiationCytarabineCell DifferentiationGraft SurvivalMyeloablative AgonistsLiver TransplantationSurvival RateHematologic NeoplasmsSurvival AnalysisVincristineLeukapheresisRetrospective StudiesBusulfanTime FactorsThiotepaCells, CulturedPrognosisCell TransplantationDoxorubicinFollow-Up StudiesDexamethasoneKidney TransplantationTransplantation ChimeraFlow CytometryLymphoma, Mantle-CellCell LineageAntineoplastic Agents, AlkylatingBone and BonesAmyloidosisLeukemia, Myeloid, AcuteAntibodies, Monoclonal, Murine-DerivedThalidomideLymphomaStem Cell FactorAntineoplastic AgentsBoronic AcidsMesenchymal Stem Cell TransplantationPyrazinesCell SeparationTissue DonorsFetal BloodLymphoma, FollicularMice, Inbred C57BLBlood Component RemovalCord Blood Stem Cell TransplantationPrednisoneLymphoma, T-Cell, PeripheralNeoplasm, ResidualMyelodysplastic SyndromesLeukemiaAntigens, CDAutograftsIfosfamideAntibodies, MonoclonalImmunosuppressive AgentsHeart TransplantationEmbryonic Stem CellsInduction ChemotherapyPodophyllotoxinLeukemia, MyeloidT-LymphocytesInterleukin-3Blood Cell CountAdult Stem CellsLung TransplantationIdarubicinCell ProliferationGranulocytes